[Pharmacokinetics and bioavailability of glipizide capsules]. 1995

Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
Zhongshan Hospital of Shanghai.

The pharmacokinetics and bioavailability of glipizide were studied in 8 healthy male volunteers after a single oral dose of 5 mg in capsule or in tablet. The plasma levels of glipizide were assayed by high performance liquid chromatography. The concentration--time curves of both preparations were fitted to a one compartment model. The pharmacokinetic parameters of glipizide in capsule and in tablet were shown in tables 2 and 3. The relative bioavailability of the capsule was 109.9% compared with the tablet.

UI MeSH Term Description Entries
D008297 Male Males
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005913 Glipizide An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. Glidiazinamide,Glydiazinamide,Glypidizine,Glucotrol,Glupitel,K-4024,Melizide,Mindiab,Minidiab,Minodiab,Ozidia,K 4024,K4024
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
January 1982, Clinical pharmacokinetics,
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
November 1979, Journal of pharmaceutical sciences,
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
November 1978, International journal of clinical pharmacology and biopharmacy,
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
January 1985, The Journal of international medical research,
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
June 2007, Zhonghua nei ke za zhi,
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
December 1977, European journal of clinical pharmacology,
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
January 2002, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
November 2005, Veterinary journal (London, England : 1997),
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
July 1978, The American journal of cardiology,
Q C Chen, and C Q Yang, and C H Chao, and Y G Ma, and X N Li, and W L Chen
September 1982, International journal of clinical pharmacology, therapy, and toxicology,
Copied contents to your clipboard!